Midgard Science

ProJect Pharmaceutics

Martinsried, Germany project-pharmaceutics.com From their website, Nov 2026

  • GLP
  • GMP

Work here? Claim this listing

About

ProJect Pharmaceutics GmbH develops formulations and manufacturing processes for injectable therapeutic products. It works with recombinant proteins, antibodies, ADCs, peptides, small molecules, viral vectors, liposomes, and nanoparticle systems for preclinical through commercial development. The company is based in Martinsried, Munich, Germany, with business development representation in Boston, MA.

Services

  • Formulation development

    Develops liquid and lyophilized injectable formulations for proteins, antibodies, peptides, ADCs, small molecules, and viral and nanoparticle systems.

  • Preformulation screening

    Screens physicochemical properties and formulation variables to identify stable and developable lead formulations.

  • High concentration & subcutaneous formulation

    Develops high-concentration formulations for subcutaneous delivery.

  • Lyophilization cycle development

    Develops freeze-drying cycles for client formulations and manufacturer equipment.

  • Downstream process development

    Develops purification and UF/DF steps around molecule stability and delivers drug substance in a usable formulation.

  • Analytical services & method development

    Runs and develops analytical methods for biologics, ADCs, cytotoxics, and viral therapeutics, including method implementation and optimization.

  • Forced degradation & stress studies

    Stresses lead formulations to identify degradation pathways and support formulation selection and method development.

  • In-use stability & clinical administration

    Simulates site preparation, dilution, holding, infusion, and injection to assess in-use stability and administration compatibility.

2 more services
  • Technology transfer to fill & finish
  • Non-GMP toxicology & stability batches
Turnaround
5 days to 6 weeks
What to send
  • Final formulation
  • Container
  • Fill volume
  • Information on your manufacturer’s dryer
  • Target product profile
  • Intended manufacturer, if known

Capabilities

Assays and studies
  • Lyophilization
  • ADCs
  • Toxicology
  • Process development
  • Antibodies
  • Fill-finish
17 more
  • Peptides
  • Small molecules
  • Bispecifics
  • Stability studies
  • SE-HPLC
  • AF4
  • DLS
  • nanoDSC
  • CG-MALS
  • cIEF
  • icIEF
  • IEX-HPLC
  • Electrophoresis
  • Light scattering
  • Calorimetry
  • Chromatography
  • Electron microscopy
Scale and capacity
  • Up to 1,000 vials per batch
  • ~1,000 2R vials per biologics batch
  • 2R to 100H vial sizes
  • Up to OEB5 cytotoxic containment
Therapeutic areas
  • Biologics
  • ADCs
  • Cytotoxics
  • Viral therapeutics
  • Live viral vaccines

Instruments and platforms

  • HOF pilot freeze-dryers
  • Wyatt Technology

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • Bispecific
  • ADC
  • Peptide
  • Viral vector
3 more
  • Recombinant protein
  • Vaccine
  • LNP / formulation

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GLPSelf-reported

    As listed: GLP-like documentation

  • GMPSelf-reported

Details

Type
CDMO
Founded
2010
Office
manufacturing 250+ short- and long-term stability runs completed 140 lyophili
Sites
  • Munich, Germany
  • Boston, MA, United States
General enquiry
info@project-pharmaceutics.com on their site

Similar labs